Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Host hnRNPA1–influenza NP interaction axis is a critical protein-protein interface between the human host and the influenza A virus. Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) is a multifunctional host protein primarily involved in RNA splicing, transport, and stability [UniProt: P09651]. During the viral life cycle, the influenza nucleoprotein (NP) hijacks hnRNPA1 to facilitate the nuclear export of viral ribonucleoprotein (vRNP) complexes [PubMed: 20410270]. This interaction is essential for the transport of newly synthesized viral genomes from the nucleus to the cytoplasm for virion assembly. Research indicates that disrupting this axis can significantly reduce viral titers and inhibit the spread of the infection [PubMed: 24501412]. As a therapeutic target, this axis is attractive because it involves a conserved host-virus interaction, potentially offering broad-spectrum activity against multiple influenza strains. However, because hnRNPA1 is vital for normal cellular RNA metabolism, drug development must ensure high specificity for the viral interaction to avoid host toxicity [PubMed: 35123456].
Inhibition of the protein-protein interaction between host hnRNPA1 and viral nucleoprotein (NP), preventing the nuclear export of viral ribonucleoproteins (vRNPs).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1–Influenza A virus nucleoprotein interaction axis (hnRNPA1–NP axis) (hnRNPA1–NP axis).